Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych VivasAddiction psychiatry — pharmaceutical and OTC misuse

Psych Vivas · Addiction psychiatry — pharmaceutical and OTC misuse

Pharmaceutical and OTC drug misuse — structured clinical viva

Fellowship viva on loperamide cardiotoxicity, pharmaceutical opioid dependence, OAT re-engagement, and the myth that OTC equals low risk.

clinical
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
You are the psychiatry registrar. ED presents a 45-year-old man with two syncopal episodes and a wide-complex rhythm that self-terminated. Empty multipacks of loperamide are in his bag. He has a history of prescription opioid dependence, lost his OAT place 8 weeks ago after missing doses, and has been taking ‘boxes of anti-diarrhoea tablets’ to feel normal. Staff ask whether this is ‘just an OTC issue’ and whether psychiatry needs to be involved. Discuss your assessment priorities, toxicology concerns, and addiction plan.

Interpretation

Reveal interpretation

This is not a trivial gastroenterology side-story. Mega-dose loperamide is used for opioid effects or withdrawal self-treatment and is associated with cardiac dysrhythmia and death (Eggleston; FAERS cardiotoxicity signals). Psychiatry/addiction involvement is mandatory once medical stabilisation begins.[1][2]

Priorities. ABC and continuous cardiac monitoring; 12-lead ECG (QRS/QTc); electrolytes; toxicology/cardiology liaison; naloxone if respiratory depression while recognising that unstable arrhythmia care dominates. Prolonged observation may be required.[1][2]

Addiction formulation. Pharmaceutical/prescription opioid dependence with loss of OAT continuity — a high-relapse, high-mortality window — now complicated by cardiotoxic self-medication. Offer OAT re-induction carefully after the gap (not automatic return to a prior high methadone dose), take-home naloxone for future opioid risk, and clear education that loperamide is dangerous at these doses.[3][4]

Staff myth-busting. “OTC” is a retail category, not a safety grade. Qualitative literature shows patients minimise pharmacy-sourced dependence; clinicians must not collude.[5]

Key points

Loperamide mega-dose

ECG and monitored care — conduction toxicity and arrest are documented.

OAT after gap

Re-engage pharmaceutical opioid dependence treatment; do not leave withdrawal untreated with cardiotoxic workarounds.

OTC myth

Pharmacy origin does not exclude life-threatening substance harm.
[1] [2] [3] [5]

References

  1. [1]Eggleston W, Clark KH, Marraffa JM. Loperamide Abuse Associated With Cardiac Dysrhythmia and Death Ann Emerg Med, 2017.PMID 27140747
  2. [2]Swank KA, et al. Cardiotoxicity associated with loperamide abuse and misuse (FAERS) J Am Pharm Assoc, 2017.PMID 28073687
  3. [3]Nielsen S, Tse WC, Larance B. Opioid agonist treatment for people who are dependent on pharmaceutical opioids Cochrane Database Syst Rev, 2022.PMID 36063082
  4. [4]Nielsen S, et al. Identifying and treating codeine dependence: a systematic review Med J Aust, 2018.PMID 29848240
  5. [5]Cooper RJ. Over-the-counter medicine abuse: a qualitative study BMJ Open, 2013.PMID 23794565